License Type: (?)






  1. Abbott Laboratories
  2. Aurora Imaging Technology, Inc.
  3. Ethicon Endo-Surgery, Inc./Johnson & Johnson
  4. Fuji Film
  5. GE Healthcare/General Electric Company
  6. Genomic Health, Inc.
  7. Hologic, Inc.
  8. iCAD, Inc.
  9. Myriad Genetics, Inc.
  10. Philips Healthcare/Royal Philips Electronics NV
  11. Sectra AB
  12. SenoRx, Inc.
  13. Siemens Healthcare/Siemens AG
  14. U-Systems, Inc.
Market Reports


U.S. MARKETS FOR BREAST CANCER DETECTION AND DIAGNOSTIC TECHNOLOGIES


351 Pages | 120 Exhibits | 2009 Analysis | Forecasts Through 2013




Enter a search phrase to search within this report:

Get the full unredacted version of this report by purchasing today.





According to the American Cancer Society (ACS), breast cancer is the most common cancer among women (excluding non-melanoma skin cancers), accounting for more than 1 in 4 cancers diagnosed in United States (U.S.) women. In 2009, approximately 192,370 women will be diagnosed with breast cancer and approximately 40,170 will die of the disease. However, due to the increased awareness, availability, and adoption of highly effective breast cancer screening technologies, the average 5-year relative survival rate for early stage, localized breast cancer now approaches 100%, emphasizing the importance of early breast cancer detection and diagnosis.

The U.S. breast cancer detection and diagnostic technologies market (defined in this report as including the 3 core imaging modalities of mammography, magnetic resonance imaging [MRI], and breast ultrasound, as well as minimally invasive breast biopsy and genetic testing) totaled more than $2.1 billion in the U.S. in 2008. This market is expected to grow at a healthy compound annual rate of 5.4% to more than $2.8 billion in 2013, despite the present economic uncertainty, impending healthcare reform, and cost/reimbursement issues.

As the population continues to age and the number of new breast cancer cases increases, the renewed importance on lowering healthcare costs will result in increased utilization of cost-effective, accurate, early cancer detection and prevention technologies. Next-generation imaging technologies that help lower the number of unnecessary biopsies while allowing for earlier detection with increased sensitivity and specificity over conventional mammography will be willingly adopted, and minimally invasive biopsy and genetic testing will continue to flourish. Minimally invasive biopsy systems will be increasingly preferred over open biopsy due to the ability to lessen patient disfigurement and pain. At the same time, the genetic testing products market will benefit from several factors including the ability to assist clinicians in recommending preventive care for women at high risk of contracting breast cancer, while sparing existing breast cancer patients unnecessary painful or ineffective chemotherapy by aiding in the selection of the most appropriate treatment plan.

This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the U.S. breast cancer detection and diagnostic technologies market. Product areas include: analog and full-field digital mammography (FFDM) systems; computer-aided detection (CAD); computed radiography detectors; MRI systems and ultrasound systems used in breast imaging; minimally invasive biopsy; BRACAnalysis and other genetic testing (recurrence risk assays); and emerging technologies such as digital tomosynthesis, next-generation breast MRI and ultrasound, and technologies developed by several start-up companies entering the breast cancer detection and diagnostic products field.



EXECUTIVE SUMMARY

i. Common Types of Breast Cancer
ii. Symptoms
iii. Risk Factors
iv. Early Detection
v. Treatment
vi. Risk Reduction
vii. Future Directions in Breast Cancer Detection
viii. Breast Cancer Detection and Diagnostic Technologies Market

Exhibit ES-1: Cancer Cases and Deaths, by Anatomic Site, 2007, 2008, and 2009
Exhibit ES-2: 2008, 5-Year Breast Cancer Survival Rates, by Stage
Exhibit ES-3: 2008, Breast Cancer Survival Rates, 5-, 10-, and 15-Years Post-Diagnosis
Exhibit ES-4: Age-Specific Risk of Developing Invasive Breast Cancer
Exhibit ES-5: 2007, Breast Cancer Cases and Deaths, by Age
Exhibit ES-6: Selected Limitations of Mammography
Exhibit ES-7: Selected Breast Cancer Imaging Technologies
Exhibit ES-8: Breast Cancer Detection and Diagnostic Technologies, Combined Market Forecast, 2008-2013
Exhibit ES-9: 2008, Breast Cancer Detection and Diagnostic Technologies Market, Share by Segment
Exhibit ES-10: 2013, Breast Cancer Detection and Diagnostic Technologies Market, Share by Segment
Exhibit ES-11: 2008, Combined Breast Cancer Detection and Diagnostic Technologies Market, Share by Supplier

1. CLINICAL OVERVIEW

1.1 Common Types of Breast Cancer
1.2 Symptoms
1.3 Risk Factors
	1.3.1 Benign Breast Conditions
	1.3.2 Family/Personal History
	1.3.3 Genetic Risks
1.4 Early Detection
1.5 Treatment
	1.5.1 Biologic Therapy, Chemotherapy, and Hormone Therapy
1.6 Risk Reduction
1.7 Future Trends in Breast Cancer Detection

Exhibit 1-1: Cancer Cases and Deaths, by Anatomic Site, 2007, 2008, and 2009
Exhibit 1-2: 2008, 5-Year Breast Cancer Survival Rates, by Stage
Exhibit 1-3: 2008, Breast Cancer Survival Rates, 5-, 10-, and 15-Years Post-Diagnosis
Exhibit 1-4: Age-Specific Risk of Developing Invasive Breast Cancer
Exhibit 1-5: 2007, Breast Cancer Cases and Deaths, by Age
Exhibit 1-6: Benign Breast Disease, by Category
Exhibit 1-7: Selected Benign Breast Diseases
Exhibit 1-8: Selected Limitations of Mammography
Exhibit 1-9: Selected Breast Cancer Imaging Technologies

2. MAMMOGRAPHY

2.1 Analog Mammography Systems
	2.1.1 GE Healthcare/General Electric
	2.1.2 Hologic
	2.1.3 Planmed/Planmeca Group
	2.1.4 Siemens Healthcare/Siemens
	2.1.5 Others
2.2 Digital Mammography Systems
	2.2.1 GE Healthcare/General Electric
	2.2.2 Hologic
	2.2.3 Siemens Healthcare/Siemens
	2.2.4 Others
2.3 Computer-Aided Detection
	2.3.1 Carestream Health/Onex
	2.3.2 Hologic
	2.3.3 iCAD
	2.3.4 Scanis
2.4 Emerging Mammography Technology
	2.4.1 BBN Technologies
	2.4.2 Dexela
	2.4.3 GE Healthcare/General Electric
	2.4.4 Konica Minolta Medical Imaging/Konica Minolta Holdings
	2.4.5 Hologic
	2.4.6 Imaging Diagnostic Systems
	2.4.7 Philips Healthcare/Royal Philips Electronics
	2.4.8 Sectra
	2.4.9 Siemens Healthcare/Siemens
	2.4.10 XCounter
	2.4.11 Others

Exhibit 2-1: Diagram of a Mammography Examination
Exhibit 2-2: BI-RADS Assessment Categories
Exhibit 2-3: 2009, Selected Analog Mammography Systems
Exhibit 2-4: Technologies Used in GE Healthcare's Diamond and Performa Analog Mammography Systems
Exhibit 2-5: Hologic's M-IV Screen-Film Mammography System
Exhibit 2-6: Hologic's MammoPad Breast Cushion
Exhibit 2-7: The Planmed Sophie Classic with MaxView Breast  Positioning System
Exhibit 2-8: Siemens Healthcare's Mammomat 1000 and 3000 Nova Mammography Systems
Exhibit 2-9: 2009, Selected Digital Mammography Systems
Exhibit 2-10: GE Healthcare's Senographe Digital Mammography Systems
Exhibit 2-11: Hologic's Selenia Digital Mammography System
Exhibit 2-12: Siemens Healthcare's Mammomat Novation and Novation S Digital Mammography Systems
Exhibit 2-13: Mammomat Digital Mammography Workflow
Exhibit 2-14: Carestream Health's Picture Archiving and Communications System with Mammography Upgrade
Exhibit 2-15: Fujifilm Medical Systems' ClearView-1m and ClearView-CSm Reader Systems
Exhibit 2-16: Mammography Scan with Computer-Aided Detection
Exhibit 2-17: 2009, Selected Computer-Aided Detection Systems
Exhibit 2-18: Carestream Health's Mammography Computer-Aided  Detection System
Exhibit 2-19: Hologic's R2 ImageChecker Computer-Aided Detection System
Exhibit 2-20: iCAD's SecondLook 300 Computer-Aided Detection Software
Exhibit 2-21: Scanis' MAMMEX MammoCAD Mammography System
Exhibit 2-22: 2009, Selected Emerging Mammography Systems
Exhibit 2-23: BBN Technologies' Stereoscopic Digital Mammography System
Exhibit 2-24: Dexela's Patented Digital Tomosynthesis Technology
Exhibit 2-25: Hologic's Selenia Dimensions Breast Tomosynthesis System
Exhibit 2-26: Imaging Diagnostic's Computed Tomography Laser Mammography System
Exhibit 2-27: Philips Healthcare's MammoDiagnost Mammography System
Exhibit 2-28: The Sectra MicroDose Mammography Detector with X-Ray Photon Counting Technology
Exhibit 2-29: XCounter's XC Mammo-3T Tomosynthesis Imaging System
Exhibit 2-30: ART Advanced Research Technologies' SoftScan Optical Imaging System

3. MAGNETIC RESONANCE IMAGING

3.1 Products
	3.1.1 Aurora Imaging Technology
	3.1.2 GE Healthcare/General Electric
	3.1.3 Philips Healthcare/Royal Philips Electronics
	3.1.4 Siemens Healthcare/Siemens
	3.1.5 Others

Exhibit 3-1: Magnetic Resonance Imaging Scan of a Breast  with Ductal Carcinoma
Exhibit 3-2: 2009, Selected Magnetic Resonance Imaging Systems Utilized in Breast Imaging
Exhibit 3-3: The Aurora 1.5T Dedicated Breast Magnetic Resonance  Imaging System
Exhibit 3-4: GE Healthcare's Signa VIBRANT 1.5T Breast Imaging System
Exhibit 3-5: Selected Components and Technologies of GE Healthcare's Breast Imaging System Module
Exhibit 3-6: Selected Components and Technologies of Philips Healthcare's Elite Breast Clinical Solutions
Exhibit 3-7: Siemens Healthcare's MAGNETOM Espree Pink 1.5T System
Exhibit 3-8: Siemens Healthcare's MAGNETOM ESSENZA 1.5T System
Exhibit 3-9: The Fonar 360° Scanner, Open Sky Room, and Upright Multi-Position Magnetic Resonance Imaging System

4. ULTRASOUND

4.1 Products
	4.1.1 Advanced Imaging Technologies
	4.1.2 GE Healthcare/General Electric
	4.1.3 Hologic
	4.1.4 Philips Healthcare/Royal Philips Electronics
	4.1.5 Siemens Healthcare/Siemens
	4.1.6 SonoCiné
	4.1.7 SonoSite
	4.1.8 TechniScan Medical Systems
	4.1.9 Terason/Teratech
	4.1.10 U-Systems
	4.1.11 Others

Exhibit 4-1: Sonogram of a Female Breast Showing Potential Cancer
Exhibit 4-2: 2009, Selected Ultrasound Breast Imaging Systems
Exhibit 4-3: Advanced Imaging Technologies' ARIA Breast Imaging System
Exhibit 4-4: GE Healthcare's LOGIQ P5 Ultrasound System
Exhibit 4-5: Hologic's DP-6600 Digital Ultrasonic Diagnostic Imaging System
Exhibit 4-6: Philips Healthcare's iU22 Ultrasound System
Exhibit 4-7: Selected Siemens Healthcare ACUSON Ultrasound Systems
Exhibit 4-8: The SonoCiné Automated Whole Breast Ultrasound System
Exhibit 4-9: SonoSite's S-Women's Health Ultrasound System
Exhibit 4-10: TechniScan Medical Systems' UltraSound CT Imaging System
Exhibit 4-11: The Terason t3000 Ultrasound System
Exhibit 4-12: U-Systems' somo•v Automated Breast Ultrasound System

5. MINIMALLY INVASIVE BREAST BIOPSY

5.1 Fine Needle Aspiration
5.2 Core Needle Biopsy
5.3 Vacuum-Assisted Breast Biopsy
5.4 Products
	5.4.1 Bard Biopsy Systems/Bard Peripheral Vascular/C.R. Bard
	5.4.2 Ethicon Endo-Surgery/Johnson & Johnson
	5.4.3 Hologic
	5.4.4 SenoRx
	5.4.5 Siemens Healthcare/Siemens
	5.4.6 Others
		5.4.6.1 Intact Medical
		5.4.6.2 Rubicor Medical
		5.4.6.3 Sanarus

Exhibit 5-1: Selected Breast Biopsy Methods
Exhibit 5-2: 2009, Selected Minimally Invasive Biopsy Systems
Exhibit 5-3: Ethicon Endo-Surgery's MAMMOTOME Breast Biopsy Device
Exhibit 5-4: Ethicon Endo-Surgery's MAMMOTOME EX Vacuum-Assisted Breast Biopsy System
Exhibit 5-5: Hologic's MultiCare Platinum Prone  Stereotactic Breast Biopsy Table
Exhibit 5-6: Hologic's ATEC and Eviva Breast Biopsy Handpieces
Exhibit 5-7: Hologic's ATEC Breast Biopsy Consoles
Exhibit 5-8: Hologic's Celero Spring-Loaded Breast Biopsy Device
Exhibit 5-9: Hologic's SecurMark and TriMark Biopsy Site Identifiers
Exhibit 5-10: SenoRx's EnCor Vacuum-Assisted Breast Biopsy System
Exhibit 5-11: SenoRx's SenoSonix II-t with EnCor Breast Biopsy System
Exhibit 5-12: SenoRx's GelMark UltraCor Biopsy Site Identifier
Exhibit 5-13: SenoRx's StarchMark Biopsy Site Identifiers
Exhibit 5-14: Siemens Healthcare's MammoTest Breast Biopsy System
Exhibit 5-15: Biopsy Procedure Using Intact Medical's Breast Lesion Excision System
Exhibit 5-16: Rubicor Medical's FLASH, HALO, and PHANTOM  Breast Biopsy Devices
Exhibit 5-17: Sanarus' Cassi II Rotational Core Biopsy System

6. GENETIC TESTING

6.1 Breast Cancer Genes 1 and 2 Test
	6.1.1 Myriad Genetics
6.2 Other Breast Cancer Genetic Assays
	6.2.1 Abbott Laboratories
	6.2.2 Abviva, Inc.
	6.2.3 Agendia
	6.2.4 Clarient
	6.2.5 Dako Denmark and Genentech/Roche Group
	6.2.6 deCODE genetics
	6.2.7 Genomic Health
	6.2.8 Siemens Healthcare/Siemens
	6.2.9 Veridex/Johnson & Johnson

Exhibit 6-1: 2009, Selected Genetic Tests for Breast Cancer
Exhibit 6-2: Risks for Breast and Ovarian Cancer Due  to Breast Cancer Gene Mutations
Exhibit 6-3: Risk-Reducing Measures for Breast and Ovarian Cancer
Exhibit 6-4: Agendia's MammaPrint Sampling Procedure
Exhibit 6-5: Benefits of the deCODE BreastCancer Test

7. EMERGING TECHNOLOGIES

7.1 Dune Medical Devices
7.2 MacKay Life Sciences/MacKay Group
7.3 Medical Tactile
7.4 Menssana Research
7.5 NeoMatrix
7.6 Z-Tech Medical
7.7 Discontinued Products
7.8 Other Technologies
	7.8.1 Positron Emission Tomography
		7.8.1.1 GE Healthcare/General Electric
		7.8.1.2 Naviscan
	7.8.2 Single Photon Emission Computed Tomography/Scintimammography
	7.8.3 Molecular Breast Imaging
		7.8.3.1 Dilon Diagnostics/Dilon Technologies

Exhibit 7-1: 2009, Selected Emerging Breast Cancer Screening Products
Exhibit 7-2: Dune Medical Devices' MarginProbe Real-Time Tissue Characterization System
Exhibit 7-3: MacKay Life Sciences' Breast Diagnostic System, Sensitivity and Specificity Rates Compared to Other Diagnostic Technologies
Exhibit 7-4: Medical Tactile's SureTouch Visual Mapping System
Exhibit 7-5: Menssana Research's Breath Collecting Apparatus
Exhibit 7-6: NeoMatrix's HALO Breast Pap Test Risk Assessment System
Exhibit 7-7: Positron Emission Tomography Scan of a Female with Metastasized Breast Cancer
Exhibit 7-8: Naviscan's Positron Emission Mammography Scanner
Exhibit 7-9: Dilon Diagnostics' Dilon 6800 Breast-Specific Gamma Imaging System

8. BREAST CANCER DETECTION AND DIAGNOSTIC TECHNOLOGIES MARKET

8.1 Mammography
	8.1.1 Market Analysis
	8.1.2 Competitive Analysis
8.2 Magnetic Resonance Imaging
	8.2.1 Market Analysis
	8.2.2 Competitive Analysis
8.3 Ultrasound
	8.3.1 Market Analysis
	8.3.2 Competitive Analysis
8.4 Minimally Invasive Breast Biopsy
	8.4.1 Market Analysis
	8.4.2 Competitive Analysis
8.5 Genetic Testing
	8.5.1 Market Analysis
	8.5.2 Competitive Analysis
8.6 Combined Market Analysis

Exhibit 8-1: Mammography Systems, Market Forecast, 2008-2013
Exhibit 8-2: Mammography, Procedure Volumes Forecast, 2008-2013
Exhibit 8-3: Mammography, Selected Statistics
Exhibit 8-4: Mammography, Medicare Reimbursement Rates, 2008-2009
Exhibit 8-5: Digital Mammography, Installed Base, 2005-2009
Exhibit 8-6: 2008, Mammography Systems Market, Share by Supplier
Exhibit 8-7: Breast Magnetic Resonance Imaging Systems, Market Forecast, 2008-2013
Exhibit 8-8: 2008, Breast Magnetic Resonance Imaging Systems Market, Share by Supplier
Exhibit 8-9: Breast Ultrasound Systems, Market Forecast, 2008-2013
Exhibit 8-10: 2008, Breast Ultrasound Systems Market, Share by Supplier
Exhibit 8-11: Minimally Invasive Breast Biopsy Systems,  Market Forecast, 2008-2013
Exhibit 8-12: 2008, Minimally Invasive Breast Biopsy Systems Market, Share by Supplier
Exhibit 8-13: Breast Cancer Genetic Testing, Market Forecast, 2008-2013
Exhibit 8-14: 2008, Breast Cancer Genetic Testing Market, Share by Supplier
Exhibit 8-15: Breast Cancer Detection and Diagnostic Technologies, Combined Market Forecast, 2008-2013 
Exhibit 8-16: 2008, Breast Cancer Detection and Diagnostic Technologies Market, Share by Segment
Exhibit 8-17: 2013, Breast Cancer Detection and Diagnostic Technologies Market, Share by Segment
Exhibit 8-18: 2008, Combined Breast Cancer Detection and Diagnostic Technologies Market, Share by Supplier

9. COMPANY PROFILES

9.1 Abbott Laboratories
9.2 Aurora Imaging Technology, Inc.
9.3 Ethicon Endo-Surgery, Inc./Johnson & Johnson
9.4 GE Healthcare/General Electric Company
9.5 Genomic Health, Inc.
9.6 Hologic, Inc.
9.7 iCAD, Inc.
9.8 Myriad Genetics, Inc.
9.9 Philips Healthcare/Royal Philips Electronics NV
9.10 Sectra AB
9.11 SenoRx, Inc.
9.12 Siemens Healthcare/Siemens AG
9.13 U-Systems, Inc.

APPENDIX:  COMPANY LISTING
Published by Medtech Insight and distributed exclusively by LSI



This report is listed in the following markets:
Diagnostics, Gynecology, Imaging and Oncology